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Abstract
Background: Both maternal uniparental disomy 14 (UPD(14)mat) and mosaic trisomy 14 are rare events in live
individuals. A combination of the two events in one individual is rarely encountered. Only six live-born cases have
so far been reported.
Case presentation: Here we reported a case of concomitant UPD(14)mat and mosaic trisomy 14 in a 10-year-old
Chinese patient. Most clinical features of our patient were consistent with those previous reported for UPD(14)mat
cases, which include prenatal and postnatal growth retardation, neonatal hypotonia, feeding difficulty, intellectual
disability, truncal obesity, small hands and feet, short stature, and mild facial dysmorphism, but our patient showed
more severe intellectual disability and no sign of precocious puberty. SNP array analysis revealed a mixture of
chromosome 14 maternal isodisomy with heterodisomy and a low level trisomy mosaicism of whole chromsome
14 in blood and hyperpigmented skin samples, whereas only UPD(14)mat was detected in normal skin sample.
Cytogenetic analysis identified one trisomy 14 cell in 100 metaphase of peripheral blood lymphocytes
(47,XX, +14[1]/46,XX[99]).
Conclusions: To our knowledge, this is the first case of a patient with UPD(14)mat and mosaic trisomy 14 reported
in a Chinese patient. The definitive genetic diagnosis is beneficial for genetic counseling and clinical management
of our patient, and for improving our understanding of the genotype-phenotype correlations of concomitant
UPD(14)mat and mosaic trisomy 14.
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Background
Uniparental disomy refers to the inheritance of two
homologous chromosomes from one parent [1]. Mater-
nal uniparental disomy 14 (UPD(14)mat) is a rare but
clinically well-established disorder which is characterized
with prenatal and postnatal growth retardation, neonatal
hypotonia, feeding difficulty, motor development delay,
mild to moderate intellectual disability, precocious
puberty, truncal obesity, small hands and feet, short sta-
ture, hyperextensible joints, and mild facial dysmorphism
[2, 3]. Since it was firstly described by Temple et al., 81
cases have been reported to date [4–11] (http://upd-tl.com/
upd.html [accessed 24/07/2016]). Most UPD(14)mat cases
were found with balanced Robertsonian translocations
or extra structurally abnormal chromosomes (ESACs),
however UPD(14)mat also occurred with normal karyo-
type [12, 13]. UPD(14)mat may be presented as isodisomy
or heterodisomy or as a mixture of both. Both maternal
iso- and heterodisomy of chromosome 14 were observed
with the similar clinical findings, which indicated that the
phenotypes were due to genomic imprinting rather than
homozygosity for a recessive gene [12].* Correspondence: chenshaoke123@163.com; yiping.shen@childrens.harvard.
edu
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Trisomy 14 mosaicism is a rare chromosomal abnorma-
lity with distinct and recognizable clinical features, inclu-
ding growth and psychomotor retardation, short neck,
congenital heart defect, genitourinary abnormalities, body
asymmetry, abnormal skin pigmentation and craniofacial
dysmorphism [14]. So far, 42 live-born cases have been
reported [15, 16].
The first case of UPD(14)mat with mosaic trisomy 14
confirmed at peripheral blood lymphocytes level was de-
scribed by Antonarakis et al. [17]. So far only six live-born
patients have been previously reported [4, 17–21], four
out of the six patients involved no Robertsonian transloca-
tions or ESACs. Here we reported a seventh live case of
UPD(14)mat and mosaicism for trisomy 14 (the fifth case




A 10-year-old Chinese boy was born to a healthy gravida
2, para 2 mother with negative family history for genetic
diseases. At the time of his birth, his mother and father
were 35 and 36 years old respectively. Ultrasonic exami-
nation showed intrauterine growth retardation and poly-
hydramnios. He was delivered by Caesarean section at full
term with a birth weight of 2350 g (3rd centile). The birth
height was unknown. He had a history of developmental
delay and neonatal hypotonia. He had delayed milestones,
feeding difficulty and week sucking and crying during the
first several months of life. At the age of five, his complete
blood count and thyroid-stimulating hormone (TSH) were
normal, but the serum growth hormone (GH) level was
very low (0.97 ng/ml). Growth hormone provocative test
showed a peak value of 2.66 ng/ml and the patient was
diagnosed with growth hormone deficiency (GHD). He
began to get fat with a growth rate of 2-3 cm per year
when he was 6 years old and his bone age was delayed
(corresponded to the age of 2 years). He is now presented
with intellectual disability, language delay, learning dif-
ficulty, attention deficit and minimal communication with
his peers. Physical examination at age of 9 years and
9 months showed a height of 118.3 cm (−6.0SD), a weight
of 27 kg (−1.5SD) (BMI = 19.3 kg2/m), and OFC of 52 cm
(50–75th percentile). He had small hands with a length of
13.5 cm and small feet with a length of 18.5 cm (The
average is 20.5 cm for Chinese boys at 7–10 years of age).
His physical features include short stature, truncal obesity,
short neck, thoracic-lumbar scoliosis, lordosis and kyphosis,
small hands and feet, fifth finger clinodactyly, buffalo hump,
barrel chest, body asymmetry, cryptorchidism on the right
side and abnormal skin pigmentation (Fig. 1). His cranio-
facial features included ocular hypertelorism, narrow pal-
pebral fissures, high arched palate, and depressed nasal
bridge. The right and left testes were 1.7*0.8*1.0 cm
and 1.7*0.9*1.1 cm in size respectively. The size of penis
was 4.0*1.5 cm without pubes. No sign of precocious
puberty was noticed. ECG examination showed sinus car-
diac arrhythmia and brain MRI examination was normal.
A recent assessment using Chinese Wechsler intelligence
scale for children (C-WISC) showed a verbal scale IQ of
35 (severe), a performance scale IQ of 55 (mild), and a full
scale IQ of 38 (severe). Raven's Standard Progressive
Matrices (RSPM) was also used to measure his intelligence.
The intelligence percentile rank was 6 %. Based on the
intelligence test results above, the patient was diagnosed
with moderate to severe intellectual disability. Meanwhile
his motor development was close to normal level. The boy
started growth hormone (GH) therapy at the age of 9 years
and 9 months. He grew 4.9 cm (from 118.3 to 123.2 cm
(−5.0SD)) during the first five months. He also gained 5 kg
of weight (from 27 to 32 kg (−0.5SD)).
Cytogenetic and molecular analyses
Peripheral blood lymphocytes, hyperpigmented and normal
skin samples were collected from the patient and genomic
DNA was extracted using Lab-Aid DNA kit (Zeesan Biotech
Co., Ltd, China). G-banding was performed on metaphase
chromosomes of cultured peripheral blood lymphocytes
of the family trio. FISH was directly conducted on inter-
phases chromosomes 14 of peripheral blood lymphocytes
with probe specific for the region 14q11.2 (Agilent, USA,
Spectrum red) on the patient. Genomic profiling were per-
formed on blood, hyperpigmented and normal skin sam-
ples of the patient and his parents’ blood samples using
Illumina Human CytoSNP 12 BeadChip array (Illumina,
San Diego, CA). The SNP array data was analyzed with
GenomeStudio and KaryoStudio software. All operative
procedures fully followed the manufacturer’s instructions.
Results
G-banding karyotyping found one trisomy 14 cell in 100
metaphase cells (47,XX, +14[1]/46,XX[99]) (Fig. 2a) in the
patient’s peripheral blood sample and the parents’ karyo-
types were normal. The SNP array analysis revealed a low
level (10–20 %) trisomy 14 mosaicism in blood and hyper-
pigmented skin samples (Fig. 2c, e) but not in the normal
skin sample (Fig. 2d). It also revealed two segments of
absence of heterozygosity (AOH) on chromosome 14, one
at 14q11.2q22.3 (chr14:22749742–57116759, NCBI build
37) and another at 14q32.2qter (chr14:97636474–107282
437, NCBI build 37), suggestive of segmental uniparental
disomy in all types of samples (Fig. 2c–e). To confirm, we
performed a parent–child trio genotyping by SNP array
using blood samples of the family and all informative SNP
data revealed that 14q11.2q22.3 and 14q32.2qter segments
were maternal isodisomic, and the other regions of chromo-
some 14 were maternal heterodisomic (Additional file 1).
The patient had a mixture of isodisomy and heterodisomy
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on chromosome 14. Thus we concluded that our patient had
tissue restricted UPD(14)mat and mosaicism for trisomy 14.
Subsequent peripheral blood lymphocyte inter-phases FISH
showed 22 trisomy 14 cells from 200 cells (47,XX,+14[22]/
46,XX[178]) (Fig. 2b).
Discussion
This is the seventh liveborn reported with a combination of
UPD(14)mat and mosaic trisomy 14 and the first case in a
Chinese patient. The presence of mosaic trisomy suggest
that UPD was formed by trisomy rescue. The finding of
tissue restricted trisomy mosaic pattern further suggested
somewhat delayed post-zygotic trisomy rescue. In addition,
the UPD(14)mat presented as a mixture of isodisomy and
heterodisomy in our patient, we speculated that at least two
crossover events had happened between the two non-sister
chromatids of homologous chromosomes at the maternal
meiosis I and a disomic gamete arose from nondisjunction
in maternal meiosis II [12].
Most of the clinical features of our patient were consis-
tent with those previous reported for UPD(14)mat cases,
which included intrauterine growth retardation, neonatal
hypotonia, short stature, truncal obesity, small hands and
feet, intellectual disability, and mild facial dysmorphism,
but our patient showed more severe intellectual disability.
In previous reports, most cases had normal intelligence
and no more than one-third of cases showed mild to
moderate intellectual disability, whereas our patients pre-
sented with moderate to severe intellectual disability [3].
In addition, our patient also presented with some clinical
features of trisomy 14 mosaicism which include polyhy-
dramnios, abnormal skin pigmentation, short neck and
cryptorchidism. We compared the clinical features of five
patients with UPD(14)mat and mosaic trisomy of whole
chromsome 14 in Table 1 (Column 4–8). We limited the
Fig. 1 Patient at age of 9 years and 9 months. a Multiple facial dysmorphisms include ocular hypertelorism, narrow palpebral fissures and
depressed nasal bridge. b, d, e Buffalo hump, thoracic-lumbar scoliosis, lordosis and kyphosis. c Short neck. f Cryptorchidism on the right
side and abnormal skin pigmentation. g, h Small hands, fifth finger clinodactyly. i Small feet
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comparison among live cases and excluded two cases with
the involvement of Robertsonian translocation [17, 18].
All cases presented hypotonia. IUGR, short stature and
truncal obesity were consistent features. It is unclear if
these features were present in the patient reported by
Pecile et al. [21]. Moderate intellectual disability was
described in two patients reported by Balbeur et al. and
Cox et al. respectively [4, 20]. The mental status was not
mentioned for the other two previously reported patients
[19, 21]. Based on the C-WISC and RSPM evaluation, our
patient was determined to have moderate to severe intel-
lectual disability. No consistent or recognizable facial
feature was identified among the five patients. In addition,
we compared the clinical features of the five patients with
the summaried features of patients with only UPD(14)mat
(Column 2) or only trisomy 14 mosaicism (Column 3). It
is noticed that the shared features among the five patients
are also consistent features in patients with UPD(14)mat.
There are few shared features between the five patients
and the patients with trisomy 14 mosaicism. The result of
comparision indicated that the clinical consequence of
patients with concomitant UPD(14)mat and trisomy 14
mosaicism is likely largely dictated by the clinical conse-
quence of maternal UPD.
Interestingly, both UPD(14)mat and trisomy 14 mosai-
cism were detected in the hyperpigmented skin of our
patient whereas only the UPD(14)mat was detected in his
normal skin. Balbeur et al. detected a similar low level tri-
somy 14 mosaicism in both hyperpigmented and normal
skin [20]. Thus it is not known if trisomy 14 mosaicism
directly contributed to the abnormal skin pigmentation
phenotype.
UPD(14)mat patients demonstrated overlapping features
with Prader-Willi syndrome (PWS) including hypotonia,
neonatal feeding difficulty and obesity. UPD(14)mat should
be considered as a differential for patients with suspected
PWS. Indeed, Mitter et al. detected four UPD(14)mat from
33 patients who were suspected to have PWS [9]. Similarly,
Hosoki et al. identified four UPD(14)mat patients from a 78
patient cohort with PWS-like phenotype without known
molecular defects for PWS [10]. However, Cox et al. did
not find any UPD(14)mat in 35 patients suspected with
PWS [4]. Further studies could help to identify other distin-
guishing features such as facial characteristics and preco-
cious puberty for differential diagnosis.
Four UPD(14)mat patients had been previously described
with GH treatment, and all patients showed beneficial
effects. But only one patient was known to have growth
hormone deficiency [9], and other three cases were treated
because of short stature without data regarding the GH
level [19, 22]. The height SDS (HSDS) of patient with
growth hormone deficiency increased from −2.5SD at age
of 6 to −1.5SD at age of 12 [9]. Two patients presented a
considerable increase in height (from −2.3SD at age of 6.9
to −1.2SD at age of 8.9, from −1.2SD at age of 9.3 to
−0.6SD at age of 11.4, respectively) and IGF-1 level (from
+0.1SD to +1.3SD, from −1.4SD to +0.9SD, respectively)
[19]. The remaining patient received growth hormone the-
rapy at age of 4 because of short stature (−3.9SD at 3 years
11 months) and obtained effective result without specific
data about height [22]. The treatment effect on body com-
position was less consistent among them. In one patient,
her weight decreased from +1.2SD to −0.7SD and the body
composition was improved (fat percentage from 51.5 % to
45.4 %), and in other patient, his weight and body compo-
sition remained stable [19]. The GH level was rarely mea-
sured among the UPD(14)mat patients, our patient was the
second case to undergo growth hormone provocative test.
Due to the complete growth hormone deficiency, our
patient started the recombinant human growth hormone
replacement treatment at the age of 9 years and 9 months.
After five months of treatment, his height increased from
−6.0SD to −5.0SD. Contrary to previous reports, his weight
increased from −1.5SD to −0.5SD which may be caused by
other unknown endocrine problems or overeating behavior.
The clinical presentation described for this patient and his
response to GH treatment is useful for future patient coun-
seling and care.
Conclusions
In summary, we described the first Chinese patient with
UPD(14)mat and mosaic trisomy 14. Our patient pre-
sented with prenatal and postnatal growth retardation,
neonatal hypotonia, feeding difficulty, intellectual disabi-
lity, short stature, truncal obesity, small hands and feet,
and mild facial dysmorphism, mostly consistent with
features known to be associated with UPD(14)mat. The
patient had complete GH deficiency and benefited for
growth hormone replacement treatment. The definitive
genetic diagnosis is beneficial for genetic counseling and
clinical management of our patient, and for improving our
understanding of the genotype-phenotype correlations of
concomitant UPD(14)mat and mosaic trisomy 14.
(See figure on previous page.)
Fig. 2 Cytogenetic and molecular results. a G-banding karyotype of the patient, showing a trisomy 14 cell detected from 100 metaphase cells.
b FISH results of analysis of interphase cells. c, e Chromosomal microarray analysis on blood and hyperpigmented skin samples showed two
AOH regions at 14q11.2q22.3 and 14q32.2qter and trisomy 14 mosaicism at about 10-20 % level, respectively. d Chromosomal microarray
analysis on normal skin sample only showed two AOH regions at 14q11.2q22.3 and 14q32.2qter
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